Amlogenyx discloses $10 million raised in convertible note offering
The Novato, California biotech reported selling half of a planned $20 million offering to two investors as of a Form D filed with the SEC.
SEC filing
Latest
1 story
Sign inSign in1 story
The Novato, California biotech reported selling half of a planned $20 million offering to two investors as of a Form D filed with the SEC.
SEC filing